Ondansetron HCL 4 MG tablet 500S
Ended Awarded
- Contract number
- SPE2DR26F0VL0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,356
Award facts
- Contract value 100% obligated
- $25,356.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets (500 tablets) under a firm fixed-price arrangement. The contract, valued at $25,356.22, was competitively awarded without set-aside designation and is scheduled for completion by October 21, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Ondansetron is an antiemetic medication commonly used to prevent nausea and vomiting, particularly in military medical and veteran healthcare settings. This delivery order exemplifies AmerisourceBergen's extensive role as a critical federal pharmaceutical supplier, with a demonstrated portfolio spanning generic and brand-name medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The contract reflects the company's continued capability to meet federal procurement requirements through open competition and supports the Defense Logistics Agency's mission to supply pharmaceutical commodities to defense and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F0VL0?
SPE2DR26F0VL0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DR26F0VL0 worth?
The government has obligated $25,356 on SPE2DR26F0VL0.
Is contract SPE2DR26F0VL0 an order under another contract?
Yes. SPE2DR26F0VL0 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0VL0 competed?
The extent of competition for SPE2DR26F0VL0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award